Structured evidence table for Saffron Attention Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Saffron Attention Randomized Trial | Difficulties in accessing healthcare, their high costs, personal preferences, and the perceived safety of medicinal herbs have contributed to the increased usage of herbalism [,,]. | 1 | Hasheminasab Fatemeh Sadat (2026) | Adverse Events of Saffron ( Crocus sativus L.): Systematic Review of Current Evidence |
| Saffron Attention Randomized Trial | Given their popularity, it is crucial to have up‐to‐date risk and benefit assessments on these herbal products []. | 1 | Hasheminasab Fatemeh Sadat (2026) | Adverse Events of Saffron ( Crocus sativus L.): Systematic Review of Current Evidence |
| Saffron Attention Randomized Trial | Therefore, compiling a systematic review of human studies with the aim of summarizing the available evidence on the side effects ofnot only fills the gap in the literature but also seems essential for physicians, researchers, and health policymakers to use this widely used medicinal plant safely and rationally. | 1 | Hasheminasab Fatemeh Sadat (2026) | Adverse Events of Saffron ( Crocus sativus L.): Systematic Review of Current Evidence |
| Saffron Attention Randomized Trial | sativus 1 1 2 2 3 Saffron (L.) is a sophisticated spice with culinary and therapeutic importance []. | 1 | Hasheminasab Fatemeh Sadat (2026) | Adverse Events of Saffron ( Crocus sativus L.): Systematic Review of Current Evidence |
| Saffron Attention Randomized Trial | In recent years, a growing body of scientific evidence supporting several of these traditional uses has shown the potential of saffron and its main ingredients—crocins, crocetin, safranal, and picrocrocin—as pharmacologically relevant compounds. | 3 | Campos Catarina (2026) | From Stigma to Therapy: Pharmacological Insights into Saffron Bioactives for Major Non-Communicable Diseases |
| Saffron Attention Randomized Trial | By integrating evidence from in vitro studies, animal models, and clinical trials, this review critically assesses saffron’s potential as a multi-target pharmacological agent and identifies key limitations and future directions for its development within pharmaceutical and integrative medicine frameworks. | 3 | Campos Catarina (2026) | From Stigma to Therapy: Pharmacological Insights into Saffron Bioactives for Major Non-Communicable Diseases |
| Saffron Attention Randomized Trial | Considering the scope of disease areas covered, this review is intended to be a broad narrative overview rather than an exhaustive systematic evaluation of each disease, with a focus on critically evaluating study quality, level of evidence, gaps between preclinical findings and clinical applicability, and limitations across sections. | 3 | Campos Catarina (2026) | From Stigma to Therapy: Pharmacological Insights into Saffron Bioactives for Major Non-Communicable Diseases |
| Saffron Attention Randomized Trial | Crocus sativus 1 2 3 4 5 6 Natural products remain one of the main sources of pharmacologically bioactive compounds (BACs) and have played a fundamental role in the development of new drugs. | 3 | Campos Catarina (2026) | From Stigma to Therapy: Pharmacological Insights into Saffron Bioactives for Major Non-Communicable Diseases |
Source documents